September 2021
In September 2021, the Group established Shanghai Jiazan Biotechnology Co., Ltd., bringing its research, development and production functions related to skin repair and anti-aging under this entity. Its operations cover three key stages.
In formulation development, the company develops formulation systems targeting impaired skin barrier function, collagen loss and photoaging. This work encompasses combinations of active ingredients, skin penetration and stability design.
In efficacy evaluation, the company establishes raw material screening criteria and in vitro, ex vivo and human efficacy evaluation models, providing quantifiable data to support formulation development.
In process transfer, the company carries out pilot-scale production and process validation, defining process parameters and quality standards that support consistent commercial-scale production. The Group’s manufacturing bases then use these specifications for batch production.
This structure establishes a division of responsibilities across research and validation, process transfer and large-scale manufacturing within the Group, shortening the time required to take new products from project initiation to commercial production.